Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis

N Engl J Med. 2016 Oct 20;375(16):1532-1543

WCO-IOF 2016: Greater BMD increase after 1 year of romosozumab vesus teripratide

Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis

Climacteric. 2018 Apr;21(2):189-195

Intra-articular or sub cutaneous vacuum drainage for Total Knee Arthroplasty?

Clin Orthop Relat Res. 2010 Aug;468(8):2168-76. Epub 2010 Feb 2

Decompression Versus Transposition for Cubital Tunnel Syndrome

J Hand Surg Am. 2008 Oct;33(8):1314.e1-12.

Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF

J Bone Joint Surg Am. 2020 ;():. 10.2106/JBJS.19.00790

SC and IM-delivered diclofenac vs Voltaren for pain following minor surgery

Pain Pract. 2015 Jan;15(1):31-9.

OTA: A novel skin closure method with subcutaneous sutures and 2-octylcyanoacrylate

Oral edoxaban vs. subcutaneous enoxaprain for VTE prophylaxis after TKA

Thromb Res. 2014 Dec;134(6):1198-204

AAOS2019: No effect of closed suction IA drain on quad strength and knee joint effusion after TKA

AAOS2018: Abaloparatide 80ug daily reduces rate of major NVFs in osteoporotic postmenopausal women

WCO-IOF 2016: Daily subcutaneous abaloparatide vs teriparatide & placebo for osteoporosis

IORA prophylaxis achieves greater vancomycin tissue concentration vs IV administration in TKA

J Arthroplasty. 2018 Jul;33(7S):S13-S18. doi: 10.1016/j.arth.2018.03.013

EFORT: Intraossesous regional vancomycin effective for antibiotic tissue levels in TKA

No significant difference for improvement of erosive hand OA pain between adalimumab and placebo

Osteoarthritis Cartilage. 2018 Jul;26(7):880-887. doi: 10.1016/j.joca.2018.02.899

Denosumab reduces risk of fractures in post-menopausal women

N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.

Enoxaparin thromboprophylaxis effective after hip replacement

J Bone Joint Surg Am. 2001 Mar;83-A(3):336-45

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

AAOS: Fondaparinux appears to be associated with elevated blood coagulation factors

Denosumab noninferior to zoledronic acid in the treatment of bone metastasis

J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22